Related Experiment Video

Updated: Jun 6, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

[Duration of antibiotic therapy in intraabdominal infections]

Emilio Maseda1, Fernando Gilsanz

  • 1Hospital Universitario La Paz, Madrid, España. emilio.maseda@gmail.com

Enfermedades Infecciosas Y Microbiologia Clinica
|December 7, 2010
PubMed

Insights

Optimizing antibiotic duration for intraabdominal infections is crucial. Short-term treatments show promise, and biomarkers like procalcitonin may enable personalized therapy to reduce resistance and costs.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pharmacology

Background:

  • Antibiotic treatment duration for infections, including intraabdominal infections, often relies on empirical data.
  • Current recommendations lack consensus due to insufficient controlled studies, leading to varied treatment lengths.

Purpose of the Study:

  • To address the controversy surrounding optimal antibiotic treatment duration for intraabdominal infections.
  • To explore the potential of short-term antibiotic strategies and novel biomarkers for personalized treatment.

Main Methods:

  • Review of current practices and evidence regarding antibiotic duration in intraabdominal infections.
  • Evaluation of emerging short-term treatment protocols (3-5 days).
  • Assessment of biomarker-guided therapy, specifically procalcitonin, for individualizing treatment length.

Main Results:

  • Empirical antibiotic duration is common but lacks strong scientific backing.
  • Short-term treatment strategies (3-5 days) have demonstrated encouraging outcomes.
  • Procalcitonin and other biomarkers offer potential for tailoring antibiotic therapy to patient response.

Conclusions:

  • Standardizing antibiotic duration for intraabdominal infections remains a challenge.
  • Shorter antibiotic courses are feasible and may mitigate risks of resistance and cost.
  • Biomarker-driven approaches represent a promising avenue for personalized infection management.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...